Razor has been selected by Versus Arthritis as a strategic partner to deliver new and innovative AI technologies which will improve how medical research, helping millions of people, is managed and communicated.
With over 18 million people in the UK with arthritis or related musculoskeletal (MSK) conditions, the scale and pace of arthritis research is not proportionate to the huge impact on society - it is Versus Arthritis’s strategic priority to rectify this. It is estimated that arthritis-related pain alone costs the health service £5 billion every year in England.
Razor will build upon existing business intelligence that exists around Versus Arthritis research portfolio, revolutionising the way that the charity maximises its research investment to improve the quality of life for people living with arthritis.
Razor will also be working on projects across the charity which will improve and streamline how people with arthritis are communicated with online, through insights available from current AI applications such as AVA, the Versus Arthritis chatbot. Unstructured data held by the charity will be also used to better understand what people with arthritis need in terms of services and health information.
Razor’s work will be focused on building upon existing tools and developing a number of new products from conception. Combining design and development sprints and an ongoing strategy, the partnership is geared towards leveraging Versus Arthritis transformative and scalable approach to capitalise on emerging possibilities within AI technology.
Ellie Mosley, Head of Client Services at Razor, commented: “Everyone at Razor was delighted to secure this partnership with such an important and impactful organisation. As a business, we are passionate about helping companies deliver on technology which puts people first. This partnership brings that mission into sharp focus. Everything we deliver for Versus Arthritis will be geared up towards helping the huge number of people with arthritis and their families which the charity serves.
“Our team will be working with the newest AI technology, harnessing data across a broad landscape. What we’re planning to deliver will ensure Versus Arthritis is locating the right knowledge at the right time for patients and for internal research programmes. We can’t wait to help develop innovative new ways of working for the charity.”
Amanda Neylon, Director of Insight, Technology and Data, at Versus Arthritis said: “The AI and machine learning landscape has changed dramatically since we began our journey with AVA, the Arthritis Virtual Assistant. There are new opportunities emerging daily where AI could help us achieve our ambitions in supporting people with arthritis and how we talk about research. Our partnership with Razor will allow us to future-proof and forge a scalable AI strategy. We’re excited by the possibilities this brings.
“We look to continually improve our offering for millions of people with arthritis and the researchers, healthcare professionals, volunteers and fundraisers who work tirelessly to ensure that in the future no one has to live with the pain, fatigue and isolation of arthritis”
The partnership is a commitment from Versus Arthritis into the future of a growing and ever-evolving technology. Since 2016, Versus Arthritis has been using AI with a mixture of valuable explorative and automation tools. This has included conversational AI and natural language processing in the form of their Arthritis Virtual Assistant (AVA).
The partnership began in April 2020 and is planned to last a minimum of 12 months.
